ADAM II IRB Approval

Institutional Review Board Notice of Approval

Principal Investigator/Project Director:
Project Title:

Arrestee Drug Abuse Monitoring Program (ADAM II)

Sponsor Agency:
Abt IRB #:

Meg Chapman

ONDCP

0239

Review Type:

Full Board,Expedited

Approval Date

12/11/2012

Type of Approval:

Study Modification

Modification Number:

#006 (11/26/12)

Please note the following requirements:

The Board’s approval of this modification does not alter your responsibilities for the project’s
continuing review.
Problems or adverse reactions: If any problems in treatment of human subjects or unexpected
adverse reactions occur as a result of this study, you must notify the IRB Chairperson or IRB
Administrator immediately.
Consent forms: In the event the approved study includes procedures for written informed consent,
you only may use consent forms that bear the Abt Associates Inc. (or local) IRB approval stamp.
Renewal: You are required to apply for renewal of approval at least annually for as long as the
study is active. Your next review date should be on or before December 14, 2013.
IRB Chair
Teresa Doksum
Abt Associates Inc.
55 Wheeler Street
Cambridge, MA 02138
617-349-2896
irb@abtassoc.com
Cc:

Date
December 17, 2012